company
as of 2026-07-01University of Aarhus
at a glance
11 trials sponsored · 22 assets in the graph
Synthesized from structured facts only — each point cited above.
Financials
SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).
Pipeline
22 assets
OlanzapineAnesthesiaBehavioral DisordersCHEMPAQDevelopmental DisordersECTEating DisordersGuided Self-Determination GSDIntellectual DisordersMood disordersNarrative therapyNeurotic disordersOrganic DisordersPersonality DisordersPregabalinPsychosocial treatment/Psychodynamic treatmentSchizophrenia DisordersSerdolectSertindoleSubstance Use DisordersTreatment-as-usualVenous blod sample
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Olanzapine
drugsmall molecule
Anesthesia
drugsmall molecule
Behavioral Disorders
drugOTHER
CHEMPAQ
drugDEVICE
drug
ECT
drugPROCEDURE
Eating Disorders
drugOTHER
Guided Self-Determination GSD
drugBEHAVIORAL